ALBUTROPIN

Glaxosmithkline Intellectual Property Limited

Application Filed: 2009-01-15

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	77649883
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Christie Baty Heinze
Attorney Docket Number	8689.0157
Law Office Assigned	M10
Employee Name	BLOHM, LINDA E

Timeline

2009-01-15	Application Filed
2009-11-10	Published for Opposition
2011-02-16	Location: INTENT TO USE SECTION
2013-03-04	Abandon
2013-03-04	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED
Entity Statement	PRIVATE COMPANY LIMITED BY SHARES
Address	980 GREAT WEST ROAD BRENTFORD MIDDLESE GB TW8 9GS
Legal Entity Type
Legal Entity State	GB

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

CHRISTIE BATY HEINZE
FINNEGAN, HENDERSON, FARABOW, GARRETT &
901 NEW YORK AVE NW
WASHINGTON, DC 20001-4432

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations, namely, fusion protein for treatment of growth hormone deficiency

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2009-01-21	1 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER	2009-03-27	2 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2009-03-31	3 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2009-03-31	4 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2009-03-31	5 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2009-09-23	6 TROA I:Incoming Correspondence
ASSIGNED TO LIE	2009-09-25	7 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE	2009-09-25	8 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2009-09-25	9 TEME I:Incoming Correspondence
EXAMINERS AMENDMENT -WRITTEN	2009-10-06	10 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2009-10-06	11 GNEA O:Outgoing Correspondence
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2009-10-06	12 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2009-10-06	13 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2009-10-06	14 CNSA P:
LAW OFFICE PUBLICATION REVIEW COMPLETED	2009-10-08	15 PREV O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2009-11-10	16 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2009-11-10	17 NPUB E:E-Mail
NOA MAILED - SOU REQUIRED FROM APPLICANT	2010-02-02	18 NOAM O:Outgoing Correspondence
TEAS EXTENSION RECEIVED	2010-07-13	19 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2010-07-13	20 EXT1 S:
EXTENSION 1 GRANTED	2010-07-13	21 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2010-07-15	22 EXRA E:E-Mail
ASSIGNED TO EXAMINER	2010-10-13	23 DOCK D:Assigned to Examiner
TEAS EXTENSION RECEIVED	2011-01-28	24 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2011-02-16	25 AITU A:Allowance for Publication
EXTENSION 2 FILED	2011-01-28	26 EXT2 S:
EXTENSION 2 GRANTED	2011-02-16	27 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2011-02-17	28 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2011-07-06	29 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2011-07-06	30 EXT3 S:
EXTENSION 3 GRANTED	2011-07-07	31 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2011-07-08	32 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2012-01-25	33 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2012-01-25	34 EXT4 S:
EXTENSION 4 GRANTED	2012-01-30	35 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2012-01-31	36 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2012-07-26	37 EEXT I:Incoming Correspondence
EXTENSION 5 FILED	2012-07-26	38 EXT5 S:
EXTENSION 5 GRANTED	2012-07-27	39 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2012-07-28	40 EXRA E:E-Mail
ASSIGNED TO EXAMINER	2012-10-05	41 DOCK D:Assigned to Examiner
ABANDONMENT - NO USE STATEMENT FILED	2013-03-04	42 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2013-03-04	43 MAB6 O:Outgoing Correspondence
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2014-05-28	44 ASGN I:Incoming Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
ALBUTROPIN 85826006 not registered Dead/Abandoned	GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED 2013-01-17
ALBUTROPIN 78448230 not registered Dead/Abandoned	Human Genome Sciences, Inc. 2004-07-09
ALBUTROPIN 77649883 not registered Dead/Abandoned	GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED 2009-01-15
ALBUTROPIN 76081975 not registered Dead/Abandoned	Principia Pharmaceutical Corporation 2000-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.